Health Condition 1: O- Medical and Surgical
Conditions
Interventions
Intervention1: Bladder wash with Ropivacaine 100mg: Ropivacaine 100mg will be used for washing the bladder through urinary catheter after transurethral resection of bladder tumor to reduce the post-op
Sponsors
Institute of Medical Science
Eligibility
Inclusion criteria
Inclusion criteria: Those undergoing transurethral resection of bladder tumor patients belonging to ASA physical status type 1&2.
Exclusion criteria
Exclusion criteria: Patients refusal Age less than 35 years and more than 75 years Patients having Coronary Artery Disease Hemodynamic unstability Cardiac Conduction Defect Coronary Artery Disease Morbid Obesity Allergy to study drugs
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To know the effect of Ropivacaine on reduction of irritative symptoms in transurethral resection of bladder tumorTimepoint: Baseline when drug will be used At every 15 minute for 1st hour. At every 30 minute for 2nd and 3rd hour. At every hour for 5 hours. | — |
Secondary
| Measure | Time frame |
|---|---|
| To know duration of hospital stay To know duration of significant hematuria and post-op bladder irrigation durationTimepoint: After 2 days of surgery After 7 days of surgery | — |
Countries
India
Contacts
Public ContactDr Atul Kumar Singh
Institute of Medical Science, BHU, Varanasi
Outcome results
None listed